Literature DB >> 24573937

Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system.

Guangde Zhou1, Jingmin Zhao, Xiaohui Ding, Deng Pan, Yanling Sun, Jianfa Yang, Yulai Zhao.   

Abstract

To summarize the pathological features of nonalcoholic liver disease (NAFLD) in China based on a histological scoring system for NAFLD designed by the Pathology Committee of NASH Clinical Research Network (NASH-CRN), the specimens of liver needle biopsies from 130 patients with NAFLD were histopathologically analyzed by haematoxylin eosin, reticular fiber and Masson trichrome stain. Immunohistochemistry staining was used to exclude non-NAFLD cases combined with clinical data. Hepatic steatosis, lobular inflammation, hepatocytic ballooning and fibrosis were presented widespread in NAFLD liver tissues. Furthermore, macrovesicular steatosis predominantly located in acinar zone 3 was the main histologic feature of NAFLD and lobular inflammation was usually presented mildly. Hepatocyte ballooning was observed in 94.6% of all 130 cases. Mild perisinusoidal fibrosis and periportal fibrosis were often observed in stage 1 cases. According to the statistic analysis, hepatic steatosis was positively correlated with lobular inflammation, hepatocytic ballooning and fibrosis (r = 0.587, 0.488, 0.374, respectively, all P value < 0.01). The number of microgranulomas, lipogranulomas and apoptotic bodies increased following severity of steatosis, lobular inflammation and fibrosis. Meanwhile, the number of megamitochondria and glycogen nuclei was paralleveled to the degree of hepatocytic ballooning (P value all < 0.01). We suggest that the role of portal inflammation should be emphasized besides hepatic steatosis, lobular inflammation, hepatocyte ballooning and fibrosis in diagnosis and evaluation of NAFLD. It needs to be further verified whether microgranulomas, lipogranulomas and apoptosis bodies could be used as histopathological markers of development of NAFLD. The number of megamitochondria is more frequently be found in NAFLD, while in alcoholic liver diseases was Mallory bodies.

Entities:  

Year:  2007        PMID: 24573937     DOI: 10.1007/s11684-007-0081-8

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  8 in total

1.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

2.  Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.

Authors:  Michel Henry Mendler; Gary Kanel; Sugantha Govindarajan
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

3.  [Guidelines for diagnosis and treatment of alcoholic liver diseases].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-03

Review 4.  Pathology of alcoholic liver disease. VA Cooperative Study Group 119.

Authors:  S W French; J Nash; P Shitabata; K Kachi; C Hara; A Chedid; C L Mendenhall
Journal:  Semin Liver Dis       Date:  1993-05       Impact factor: 6.115

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 7.  Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.

Authors:  Amedeo Lonardo; Luigi E Adinolfi; Paola Loria; Nicola Carulli; Giuseppe Ruggiero; Christopher P Day
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

8.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.